cilostazol has been researched along with fluorescein-5-isothiocyanate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, Y; Hase, Y; Ihara, M; Ito, H; Kitamura, A; Maki, T; Nakabayashi, H; Okamoto, Y; Takahashi, R; Washida, K | 1 |
| Hara, H; Iwama, T; Mishiro, K; Shimazawa, M; Takagi, T; Yoshimura, S | 1 |
| Hiramachi, T; Kamizi, H; Kasaoka, S; Kawakami, A; Kubota, A; Matsuo, A; Mochigoe, A; Nagata, S; Tanaka, Y; Yoshikawa, H | 1 |
3 other study(ies) available for cilostazol and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
Topics: Administration, Oral; Animals; Antigens, CD; Brain; Brain Edema; Brain Ischemia; Calcium-Binding Proteins; Cerebrovascular Circulation; Cilostazol; Dextrans; Disease Models, Animal; Drug Administration Schedule; Fluorescein-5-isothiocyanate; Hemorrhage; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Microfilament Proteins; Motor Activity; Phosphodiesterase Inhibitors; Reperfusion; Statistics, Nonparametric; Tetrazoles; Time Factors; Tissue Plasminogen Activator | 2012 |
The phosphodiesterase III inhibitor cilostazol ameliorates ethanolinduced endothelial dysfunction.
Topics: Adherens Junctions; Blood Vessels; Brain; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Central Nervous System Depressants; Cilostazol; Dextrans; Dose-Response Relationship, Drug; Endothelial Cells; Ethanol; Fluorescein-5-isothiocyanate; Gene Expression Regulation; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Phosphodiesterase 3 Inhibitors; Reactive Oxygen Species; Tetrazoles; Time Factors; Zonula Occludens-1 Protein | 2014 |
Effect of Absorption Behavior of Solubilizers on Drug Dissolution in the Gastrointestinal Tract: Evaluation Based on In Vivo Luminal Concentration-Time Profile of Cilostazol, a Poorly Soluble Drug, and Solubilizers.
Topics: Animals; Area Under Curve; Cilostazol; Dextrans; Dimethyl Sulfoxide; Excipients; Fluorescein-5-isothiocyanate; Gastrointestinal Tract; Intestinal Absorption; Male; Rats; Rats, Wistar; Solubility; Tetrazoles; Vitamin E | 2016 |